Eversept Partners, LP Global Blood Therapeutics, Inc. Transaction History

Eversept Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $524,400 - $705,180	-13,800 Closed	0 $0
Q2 2018 Nov 08, 2023	SELL	$38.7 - $50.15 $154,800 - $200,600	-4,000 Reduced 22.47%	13,800 $623,000
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $154,800 - $200,600	-4,000 Reduced 22.47%	13,800 $624,000
Q1 2018 Nov 08, 2023	BUY	$39.6 - $65.9 $704,880 - $1.17 Million	17,800 New	17,800 $860 Million
Q1 2018 May 14, 2018	SELL	$39.6 - $65.9 $831,600 - $1.38 Million	-21,000 Reduced 54.12%	17,800 $860,000
Q4 2017 Nov 08, 2023	BUY	$29.7 - $45.7 $1.15 Million - $1.77 Million	38,800 New	38,800 $1.53 Billion
Q4 2017 Feb 12, 2018	BUY	$29.7 - $45.7 $1.15 Million - $1.77 Million	38,800	38,800 $1.53 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.